July 27, 2016.
Staphylococcus aureus could be a trigger for eczema flare-ups. This is what Dutch doctors suggest in a recent study, which promises new and more effective treatments for patients with this type of atopic dermatitis.
Most patients with eczema are carriers of Staphylococcus aureus
Eczema is a chronic disease common in children and adults. Although it is known to dermatologists, it also retains an element of mystery for specialists who do not know the exact origin of this condition. A new study, led by the Department of Dermatology at the Erasmus University Medical Center in Rotterdam, could be a game-changer by shedding new light on this disease. According to these researchers, Staphylococcus aureus would indeed play a significant role in triggering eczema outbreaks.
Staphylococcus aureus, also known as Staphylococcus aureus or S. aureus, would indeed be present in nearly 70% of the 9,000 patients studied. and showing skin lesions symptomatic of eczema, these scientists reveal in findings published in the British Journal of Dermatology. This proportion increases even in patients with a particularly severe form of the disease.
Towards the creation of new, more effective treatments
” This analysis shows the importance of colonization by S. aureus as a risk factor in the pathogenesis of atopic dermatitis. », Explains Suzanne Pasmans, professor of pediatric dermatology and main author of this study. Although further research is planned to confirm this hypothesis, this discovery could well revolutionize the current means of treatment of the disease.
Today, eczema patients are treated with corticosteroids and antibiotics, two substances which lose their effectiveness when used too often and which can have harmful consequences on health. The staphylococcus aureus track would make it possible to imagine new treatments, more effective in the short as well as in the long term.
Read also: Fighting eczema with burdock
